CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geist, R. T.
Right arrow Articles by Gutmann, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geist, R. T.
Right arrow Articles by Gutmann, D. H.

Cell Growth & Differentiation, Vol 6, Issue 11 1477-1483, Copyright © 1995 by American Association of Cancer Research

ARTICLES

The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord

RT Geist and DH Gutmann
Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Tuberous sclerosis (TS) is an autosomal dominant multisystem disorder characterized by the widespread development of hamartomas in many tissues and organs. TSC2 is predicted to encode a 1784-amino acid tumor suppressor protein that may function, in part, as a GTPase-activating protein for Rap1. Given the high incidence of central nervous system abnormalities in individuals affected with tuberous sclerosis, the expression of TSC2 in developing and adult nervous system tissues was examined. Reverse transcription-PCR, Northern blot, and in situ hybridization analyses demonstrated high levels of expression of TSC2 in the adult brain and developing central nervous system. Abundant TSC2 expression was detected in the adult cerebellum, hippocampus, and olfactory bulb, with lower levels of expression observed in other tissues, including heart and kidney. This enrichment of TSC2 expression in neurons in the central nervous system suggests unique roles for this tumor suppressor gene product in the development and differentiation of nervous system tissues.


This article has been cited by other articles:


Home page
 J Child NeurolHome page
P. B. Crino
Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex
J Child Neurol, September 1, 2004; 19(9): 716 - 725.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
M. H. Hyman and V. H. Whittemore
National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex
Arch Neurol, May 1, 2000; 57(5): 662 - 665.
[Full Text] [PDF]

Home page
 NeurologyHome page
P. B. Crino and E. P. Henske
New developments in the neurobiology of the tuberous sclerosis complex
Neurology, October 22, 1999; 53(7): 1384 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Rennebeck, E. V. Kleymenova, R. Anderson, R. S. Yeung, K. Artzt, and C. L. Walker
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development
PNAS, December 22, 1998; 95(26): 15629 - 15634.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.